S. Mead

J. Whittaker, S. Mead, J. Collinge, 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Inherited prion disease with 5-OPRI

S. Mead, J. Collinge, S. Joiner, 2007, Neurology.

A new prion disease: relationship with central and peripheral amyloidoses

S. Mead, M. Reilly, 2015, Nature Reviews Neurology.

TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

N. Fox, C. Cotman, J. Grafman, 2014, Acta Neuropathologica.

Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia

L. Petrucelli, S. Mead, J. Collinge, 2013, Acta Neuropathologica.

FUS pathology deﬁnes the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

P. Deyn, J. Trojanowski, M. Rossor, 2010 .

White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, NeuroImage: Clinical.

A Newly Formed Amyloidogenic Fragment due to a Stop Codon Mutation Causes Familial British Dementia

G. Plant, S. Mead, T. Révész, 2000, Annals of the New York Academy of Sciences.

The presenilin 1 P264L mutation presenting as non-fluent/agrammatic primary progressive aphasia.

Colin J. Mahoney, S. Mead, J. Warren, 2013, Journal of Alzheimer's disease : JAD.

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Enrico Amico, Philippe Allain, Mark Mühlau, 2017, The Lancet. Neurology.

The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues

S. Mead, I. Woollacott, 2014, Acta Neuropathologica.

Prion protein (PRNP) genotypes in frontotemporal lobar degeneration syndromes

M. Rossor, S. Mead, J. Collinge, 2006, Annals of neurology.

Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression

S. Mead, J. Collinge, G. Jackson, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Plasma tau is increased in frontotemporal dementia

Nick C Fox, J. Schott, S. Mead, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Corticobasal syndrome associated with a novel 1048_1049insG progranulin mutation

S. Mead, J. Collinge, T. Révész, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s disease: a case series

Nick C Fox, Tamas Revesz, Gary Adamson, 2016, The Lancet Neurology.

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Nick C Fox, Jennifer M. Nicholas, J. Morris, 2019, The Lancet Neurology.

Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion

S. Mead, B. Traynor, R. Orrell, 2015, Neurobiology of Aging.

Dementia and Cognitive Impairment

Nick C. Fox, Jason D. Warren, Martin N. Rossor, 2016 .

Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Nick C Fox, Michelle K. Lupton, Charles C. White, 2019, Nature Genetics.

Seven‐year discordance in age at onset in monozygotic twins with inherited prion disease (P102L)

S. Mead, J. Collinge, A. Schapira, 2009, Neuropathology and applied neurobiology.

Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate

S. Mead, S. Mead, J. Ironside, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C. Fox, Pietro Pietrini, Alexander Gerhard, 2018, Nature Medicine.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

Kevin F. Bieniek, C. Geula, M. Mesulam, 2018, Lancet Neurology.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal dementia and GRN mutations : a genome-wide association study

Elizabeth, Sandro, Ying-xue, 2018 .

Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity.

P. Lantos, S. Mead, J. Collinge, 2006, Brain : a journal of neurology.

DNA methylation analysis of archival lymphoreticular tissues in Creutzfeldt-Jakob disease and the prevalence of vCJD infection in the UK

S. Mead, J. Collinge, H. Hummerich, 2022, medRxiv.

Questionnaire to reduce the risk of iatrogenic prion disease transmission.

S. Mead, J. Collinge, K. Prout, 2005, The Journal of hospital infection.

ORIGINAL RESEARCH High-b-Value Diffusion MR Imaging and Basal Nuclei Apparent Diffusion Coefficient Measurements in Variant and Sporadic Creutzfeldt-Jakob Disease

S. Mead, J. Collinge, J. Thornton, 2010 .

A small deletion in C9orf72 hides a proportion of expansion carriers in FTLD

Janel O. Johnson, D. Mann, S. Mead, 2015, Neurobiology of Aging.

A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia

Colin J. Mahoney, M. Rossor, S. Mead, 2014, Neuropathology and applied neurobiology.

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2022, Journal of Neuroinflammation.

Severe vasculitic neuropathy following influenza vaccination

S. Mead, J. Hull, H. Modarres-Sadeghi, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

A novel presenilin 1 deletion (p.L166del) associated with early onset familial Alzheimer's disease

M. Rossor, C. Mummery, S. Mead, 2007, European journal of neurology.

Huntington’s disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing exploration

S. Mead, H. Hummerich, A. Rosser, 2022, bioRxiv.

The CBI‐R detects early behavioural impairment in genetic frontotemporal dementia

Nick C Fox, M. Freedman, S. Ourselin, 2022, Annals of clinical and translational neurology.

CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia.

Nick C Fox, M. Rossor, S. Mead, 2016, Brain : a journal of neurology.

LETTER TO THE EDITOR CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia

Nick C Fox, M. Rossor, S. Mead, 2016 .

CHCHD 10 Pro 34 Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia

Nick C Fox, M. Rossor, S. Mead, 2016 .

Phenotypic variability in the brains of a family with a prion disease characterized by a 144‐base pair insertion in the prion protein gene

P. Lantos, M. Rossor, S. Mead, 2003, Neuropathology and applied neurobiology.

Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions

Shona Clegg, Nick C Fox, Colin J. Mahoney, 2012, Alzheimer's Research & Therapy.

The neuroimaging phenotype of frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion

Nick C Fox, Colin J. Mahoney, J. Hardy, 2012, Alzheimer's & Dementia.

Parietal lobe deficits are a feature of frontotemporal lobar degeneration caused by a mutation in the progranulin gene

Nick C Fox, E. Warrington, J. Hardy, 2007 .

The TMEM106B risk allele is associated with lower cortical volumes in a clinically diagnosed frontotemporal dementia cohort

M. Jorge Cardoso, S. Mead, M. Bocchetta, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia

Y. Pijnenburg, S. Mead, J. Veldink, 2022, Acta Neuropathologica Communications.

Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia

S. Mead, J. Collinge, J. Beck, 2001, Neurology.

A common single-nucleotide variant in T is strongly associated with chordoma

P. Talmud, P. Tarpey, S. Mead, 2012, Nature Genetics.

diagnosed frontotemporal dementia cohort lower cortical volumes in a clinically The TMEM 106 B risk allele is associated with

S. Mead, M. Bocchetta, J. Rohrer, 2017 .

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (vol 41, pg 1088, 2009)

Nick C Fox, Moskvina, D. Rujescu, 2013 .

Y. Pijnenburg, S. Mead, J. Veldink, 2022, Acta Neuropathologica Communications.

Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease

Nick C Fox, W. M. van der Flier, A. Uitterlinden, 2022, Nature Genetics.

Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration

Nick C. Fox, Sebastien Ourselin, Jason D. Warren, 2011, Brain : a journal of neurology.

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

M. Jorge Cardoso, Nick C Fox, Jennifer M. Nicholas, 2016, Neurology.

Serum neurofilament light in familial Alzheimer disease A marker of early neurodegeneration

Nick C Fox, K. Blennow, M. Rossor, 2022 .

Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study

Nick C Fox, K. Blennow, C. Frost, 2020, Molecular Psychiatry.

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Nick C Fox, K. Blennow, C. Frost, 2019, Alzheimer's Research & Therapy.

Behçet's syndrome may present with partial seizures

G. Plant, S. Mead, D. Kidd, 2000, Journal of neurology, neurosurgery, and psychiatry.

Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease

D. Grozeva, M. Gill, M. Hill, 2019, PloS one.

Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series

J. Hardy, M. Rossor, S. Mead, 2012, Neurobiology of Aging.

Review: Clinical, genetic and neuroimaging features of frontotemporal dementia

S. Mead, J. Rohrer, R. Convery, 2019, Neuropathology and applied neurobiology.

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Nick C Fox, Catherine A. Macleod, W. M. van der Flier, 2022, Nature Genetics.

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

W. M. van der Flier, M. Fornage, D. Rujescu, 2021, Nature Communications.

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Nick C Fox, Michelle K. Lupton, Charles C. White, 2019, Nature Genetics.

Genetic Variability in CLU and Its Association with Alzheimer's Disease

Nick C Fox, M. Nalls, A. Singleton, 2010, PloS one.

Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease

Nick C. Fox, Bruce L. Miller, Martin N. Rossor, 2016, Alzheimer's & Dementia.

The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.

Thomas W. Mühleisen, Michelle K. Lupton, A. Singleton, 2012, Journal of Alzheimer's disease : JAD.

Structural Variants Create New Topological-Associated Domains and Ectopic Retinal Enhancer-Gene Contact in Dominant Retinitis Pigmentosa

S. Mundlos, S. Mead, M. Mhlanga, 2020, American journal of human genetics.

Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

Nick C Fox, Alan J. Thomas, D. Hernandez, 2021, Biological Psychiatry.

Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations

S. Mead, T. Révész, J. Rohrer, 2015, Neuropathology and applied neurobiology.

How does the genetic assassin select its neuronal target?

E. Fisher, S. Mead, J. C. Stevens, 2011, Mammalian Genome.

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

R. Petersen, J. Trojanowski, M. Rossor, 2010, Acta Neuropathologica.

A stop-codon mutation in the BRI gene associated with familial British dementia

Agueda Rostagno, Jorge Ghiso, Ruben Vidal, 1999, Nature.

Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study

Jennifer M. Nicholas, M. Freedman, N. Fox, 2021, Alzheimer's & dementia.

Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2020, Cortex.

Ascertainment bias causes false signal of anticipation in genetic prion disease.

E. Minikel, A. Karch, S. Mead, 2014, American journal of human genetics.

New insights on the genetic etiology of Alzheimer’s and related dementia

Nick C Fox, Catherine A. Macleod, W. M. van der Flier, 2020 .

Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series

Nick C Fox, M. Rossor, C. Mummery, 2018, Molecular Psychiatry.

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

E. Haan, P. Pietrini, R. Petersen, 2017, Scientific Reports.

D. Hernandez, M. Nalls, L. Ferrucci, 2017, bioRxiv.

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

Janel O. Johnson, D. Hernandez, M. Nalls, 2012, The Lancet Neurology.

Frontotemporal dementia and its subtypes: a genome-wide association study

Alexander Gerhard, Adrian Danek, Luigi Ferrucci, 2014, The Lancet Neurology.

C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis

M. Rossor, S. Mead, R. Orrell, 2015, The Lancet Neurology.

Review: Fluid biomarkers in the human prion diseases

S. Mead, A. Thompson, 2019, Molecular and Cellular Neuroscience.

Evaluating the causality of novel sequence variants in the prion protein gene by example

T. Truelsen, S. Mead, J. Collinge, 2018, Neurobiology of Aging.

Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors.

S. Mead, J. Collinge, S. Joiner, 2011, Brain : a journal of neurology.

Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series

S. Mead, J. Collinge, E. Storey, 2008, Brain : a journal of neurology.

Marked abnormalities of plasma protein biomarkers in Creutzfeldt-Jakob disease (CJD)

S. Mead, 2020, Journal of Neurology Neurosurgery & Psychiatry.

MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease

J. Stevens, S. Mead, J. Collinge, 2012, BMC Neurology.

Prion protein gene M232R variation is probably an uncommon polymorphism rather than a pathogenic mutation.

S. Mead, J. Collinge, J. Beck, 2012, Brain : a journal of neurology.

Age at onset in genetic prion disease and the design of preventive clinical trials.

E. Minikel, S. Mead, J. Laplanche, 2019, Neurology.

Genetic risk factors for Creutzfeldt-Jakob disease

S. Mead, E. Jones, 2020, Neurobiology of Disease.

A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2021, Brain : a journal of neurology.

Age of onset in genetic prion disease and the design of preventive clinical trials

E. Minikel, S. Mead, J. Laplanche, 2018, bioRxiv.

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis

Veronica Redaelli, Sebastien Ourselin, Martina Bocchetta, 2015, The Lancet Neurology.

Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation

Nick C Fox, S. Mead, J. Collinge, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

High-b-Value Diffusion MR Imaging and Basal Nuclei Apparent Diffusion Coefficient Measurements in Variant and Sporadic Creutzfeldt-Jakob Disease

J Collinge, P Rudge, H R Jäger, 2010, American Journal of Neuroradiology.

Tau, prions and Aβ: the triad of neurodegeneration

S. Mead, J. Collinge, P. Rudge, 2010, Acta Neuropathologica.

Validation of next-generation sequencing technologies in genetic diagnosis of dementia

Nick C Fox, M. Rossor, J. Schott, 2014, Neurobiology of Aging.

Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, Neurobiology of Aging.

Exome sequencing identifies rare damaging variants in the ATB8B4 and ABCA1 genes as novel risk factors for Alzheimer’s disease

W. M. van der Flier, A. Uitterlinden, R. Redon, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Rare structural genetic variation in human prion diseases

S. Mead, J. Collinge, I. Zerr, 2015, Neurobiology of Aging.

A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.

Andrew King, Nick C Fox, Tamas Revesz, 2008, Brain : a journal of neurology.

Genome wide association studies and prion disease

S. Mead, A. Lukić, 2011, Prion.

Shared genetic contribution to ischemic stroke and Alzheimer's disease

Nick C Fox, C. Sudlow, J. Gallacher, 2016, Annals of neurology.

Genome-wide association study of behavioural and psychiatric features in human prion disease

S. Mead, J. Collinge, J. Lowe, 2015, Translational Psychiatry.

Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings.

S. Mead, T. Révész, J. Ghiso, 2000, Brain : a journal of neurology.

Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales

Nick C Fox, M. Freedman, S. Ourselin, 2018, Alzheimer's research & therapy.

Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations☆

Sébastien Ourselin, Marc Modat, Nick C. Fox, 2010, NeuroImage.

Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene.

Nick C Fox, J. Hardy, M. Rossor, 2013, JAMA neurology.

Altered body schema processing in frontotemporal dementia with C9ORF72 mutations

Colin J. Mahoney, Phillip D. Fletcher, Hannah L. Golden, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2020, NeuroImage: Clinical.

Mapping the progression of progranulin-associated frontotemporal lobar degeneration

Richard Boyes, Rohani Omar, Josephine Barnes, 2008, Nature Clinical Practice Neurology.

Serum neurofilament light in familial Alzheimer disease

Nick C Fox, K. Blennow, M. Rossor, 2017, Neurology.

PRION-1 scales analysis supports use of functional outcome measures in prion disease

S. Mead, J. Collinge, P. Rudge, 2011, Neurology.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2017, Nature Communications.

Differential early subcortical involvement in genetic FTD within the GENFI cohort

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2021, NeuroImage: Clinical.

Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features

Nick C Fox, Colin J. Mahoney, E. Warrington, 2012, Alzheimer's & Dementia.

Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene.

Rohani Omar, Nick C Fox, John Hardy, 2008, Archives of neurology.

Exome sequencing identifies rare damaging variants in the ATP8B4 and ABCA1 genes as novel risk factors for Alzheimer’s Disease

Nick C Fox, Davide, A. Uitterlinden, 2020 .

Progressive logopenic/phonological aphasia: Erosion of the language network

Sébastien Ourselin, Martin Rossor, Gerard R. Ridgway, 2010, NeuroImage.

Minimise transmission risk of CJD and vCJD in healthcare settings. Report on the Prevention of CJD and vCJD by Advisory Committee on Dangerous Pathogens' Transmission Spongiform Encephalopathy (ACDP TSE) Subgroup.

D. Jeffries, R. Cumming, A. Fraise, 2015 .

A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members

G. Plant, S. Mead, N. Wood, 2001, Journal of neurology, neurosurgery, and psychiatry.

No evidence that extended tracts of homozygosity are associated with Alzheimer's disease

Michelle K. Lupton, M. Gill, M. Owen, 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Nature Medicine.

A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Brain : a journal of neurology.

Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes

Nick C Fox, W. M. van der Flier, A. Uitterlinden, 2022, Genome Medicine.

Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutation

J. Molinuevo, S. Mead, R. Guerreiro, 2016, Neurobiology of Aging.

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Nick C Fox, N. Fox, K. Blennow, 2019, Alzheimer's Research & Therapy.

Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia

Nick C Fox, Elizabeth Gordon, Tamas Revesz, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes

M. Rossor, S. Mead, J. Collinge, 2011, Journal of Neurology.

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

Nick C Fox, D. Hernandez, M. Nalls, 2017, Scientific Reports.

Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions

Nick C Fox, Colin J. Mahoney, Hannah L. Golden, 2012, Alzheimer's Research & Therapy.

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

Jennifer M. Nicholas, M. Freedman, S. Ourselin, 2021, Molecular Neurodegeneration.

Mapping prion pathology in mice using quantitative imaging: an MRI study

X. Golay, S. Mead, J. Collinge, 2021 .

Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis

D. Neary, S. Mead, S. Rollinson, 2011, Neurobiology of Aging.

Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration

D. Neary, M. Rossor, N. Cairns, 2009, Neurobiology of Aging.

Rapid communication Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration

D. Neary, M. Rossor, N. Cairns, 2009 .

OP-BRAI180237 2895..2907

D. Hernandez, M. Nalls, A. Singleton, 2018 .

HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q

Nick C Fox, M. Rossor, S. Mead, 2009, BMC Medical Genetics.

Letter

S. Mead, J. Collinge, P. Rudge, 2011 .

The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report

Nick C Fox, C. Blauwendraat, S. Mead, 2016, Alzheimer's & dementia.

Genome-wide association study identifies risk variants for sporadic Creutzfeldt-Jakob disease in STX6 and GAL3ST1

A. Aguzzi, H. Budka, G. Jansen, 2020, medRxiv.

A novel prion protein variant in a patient with semantic dementia

M. Rossor, S. Mead, J. Collinge, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Lecanemab slows Alzheimer's disease: hope and challenges

Nick C Fox, S. Mead, 2023, Lancet Neurology.

Plasma Aβ ratios in autosomal dominant Alzheimer’s disease: the influence of genotype

Nick C Fox, Jennifer M. Nicholas, K. Blennow, 2021, bioRxiv.

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

Janel O. Johnson, D. Hernandez, M. Nalls, 2012, The Lancet Neurology.

Empowering Better End‐of‐Life Dementia Care (EMBED‐Care): A mixed methods protocol to achieve integrated person‐centred care across settings

S. Mead, R. Omar, E. Sampson, 2019, International journal of geriatric psychiatry.

Common variants at ABCA 7 , MS 4 A 6 A / MS 4 A 4 E , EPHA 1 , CD 33 and CD 2 AP are associated with Alzheimer ’ s disease

Nick C Fox, John X. Morris, Thomas W. Mühleisen, 2011 .

CXCR4 involvement in neurodegenerative diseases

O. Andreassen, G. Schellenberg, A. Dale, 2017, bioRxiv.

Large meta-analysis of genome-wide association studies expands knowledge of the genetic etiology of Alzheimer disease and highlights potential translational opportunities

Pavel P. Kuksa, D. Rujescu, S. Djurovic, 2020, medRxiv.

Rare structural genetic variation in human prion diseases.

S. Mead, J. Collinge, I. Zerr, 2015, Neurobiology of aging.

A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea

M. Alpers, S. Mead, J. Collinge, 2008, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features

Nick C Fox, Colin J. Mahoney, E. Warrington, 2012, Alzheimer's & Dementia.

Exome sequencing identifies novel AD-associated genes.

Nick C Fox, R. Redon, D. Grozeva, 2020, medRxiv.

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2022, Journal of Neuroinflammation.

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

Janel O. Johnson, D. Hernandez, G. Schellenberg, 2012, The Lancet Neurology.

Plasma amyloid-β ratios in autosomal dominant Alzheimer’s disease: the influence of genotype

Nick C Fox, Jennifer M. Nicholas, K. Blennow, 2021, Brain : a journal of neurology.

Imaging biomarkers for the diagnosis of Prion disease

Sébastien Ourselin, M. Jorge Cardoso, Marc Modat, 2018, Medical Imaging.

Behavioral and psychiatric symptoms in prion disease.

S. Mead, J. Collinge, P. Rudge, 2014, The American journal of psychiatry.

ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology

Nick C Fox, J. Rowe, J. Schott, 2019, Alzheimer's & dementia.

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

P. Pietrini, R. Desikan, J. Trojanowski, 2019, Scientific Reports.

The heritability and genetics of frontotemporal lobar degeneration

Nick C Fox, M. Rossor, S. Mead, 2009, Neurology.

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Genetic, Nick C Fox, Michelle K. Lupton, 2019, Nature Genetics.

Common polygenic variation can predict risk of Alzheimer ’ s disease

Cornelia, M. Gill, G. Schellenberg, 2016 .

A novel prion protein variant in a patient with semantic dementia

M. Rossor, S. Mead, J. Collinge, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Late onset hereditary sensory and autonomic neuropathy with cognitive impairment associated with Y163X prion mutation

M. Husain, S. Mead, Jacqueline A Palace, 2014, Journal of Neurology.

Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

Thomas W. Mühleisen, Michelle K. Lupton, A. Singleton, 2010, PloS one.

Gene-Based Analysis in HRC Imputed Genome Wide Association Data Identifies Three Novel Genes For Alzheimer’s Disease

D. Grozeva, P. Holmans, R. Sims, 2018, bioRxiv.

Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study

Nick C Fox, K. Blennow, C. Frost, 2020, Molecular Psychiatry.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

C. Geula, M. Mesulam, J. Grafman, 2019, Acta Neuropathologica.

Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertained

Nick C Fox, S. Mead, J. Collinge, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Behavioral and psychiatric symptoms in prion disease.

S. Mead, J. Collinge, P. Rudge, 2014, The American journal of psychiatry.

HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q

Nick C Fox, M. Rossor, S. Mead, 2009, BMC Medical Genetics.

Comment on validation of diagnostic criteria for variant Creutzfeldt‐Jakob disease

S. Mead, J. Collinge, P. Rudge, 2011, Annals of neurology.

Exome sequencing identifies three novel AD‐associated genes

W. M. van der Flier, D. Grozeva, R. Sims, 2020 .

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Nick C Fox, Pavel P. Kuksa, W. M. van der Flier, 2022, Nature Genetics.